Galantamine is a prescription medication classified under neurology and used primarily to manage symptoms of Alzheimer’s disease. It is available as a pill in strengths of 4 mg and 8 mg. In Hong Kong, galantamine is regulated by the Department of Health and requires a physician’s prescription.
Galantamine belongs to the class of acetylcholinesterase inhibitors. It works by two complementary mechanisms:
These actions begin within hours of the first dose, with peak effects typically observed after several weeks of consistent therapy as the brain adapts to higher cholinergic activity.
Galantamine is approved by major regulatory agencies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), for the symptomatic treatment of mild to moderate Alzheimer’s disease. In Hong Kong, the same indications apply under local prescribing guidelines. The medication does not cure Alzheimer’s disease but can modestly improve cognition, daily functioning, and behavior in many patients.
Typical patients are adults diagnosed with early-stage Alzheimer’s who have adequate liver function and can swallow pills. Treatment decisions are individualized by neurologists or geriatric specialists.
Evidence from limited clinical studies suggests potential benefit of galantamine in Lewy body dementia and vascular dementia. However, these uses are not approved by regulatory authorities in Hong Kong and should only be considered under specialist supervision.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
Absolute contraindications
Relative contraindications and special considerations
If any of these conditions apply, the prescriber may opt for an alternative therapy or adjust the dosing regimen.
Patients should provide a complete medication list-including over-the-counter drugs, supplements, and herbal products-to their prescriber.
This article provides educational information about galantamine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Galantamine may be combined with other cholinesterase inhibitors (e.g., donepezil) only under specialist supervision, as additive effects can increase side-effect risk. Combination with memantine is more common and generally considered safe.
Take the medication with a light snack or at bedtime, and maintain adequate hydration. If nausea persists beyond the first few weeks, contact your prescriber for possible dose adjustment.
Patients with mild to moderate renal impairment can usually continue standard dosing, but those with severe impairment may need a reduced dose or close monitoring.
Clinical benefits often become apparent after 4-6 weeks of consistent therapy, though individual responses vary.
The drug can cause modest reductions in blood pressure, especially in patients prone to bradycardia. Monitoring is advisable in individuals on antihypertensive therapy.
Evidence is limited; galantamine is not approved for this indication in Hong Kong. Off-label use should be considered only after specialist evaluation.
Common excipients include lactose monohydrate, maize starch, and magnesium stearate. Patients with lactose intolerance should discuss alternatives with their pharmacist.
Carry the medication in its original packaging with a copy of the prescription. Keep pills in a carry-on bag to avoid temperature extremes in checked luggage.
Galantamine is not a controlled substance and is not typically screened for in standard occupational or anti-doping tests.
Generic pills are generally less expensive than branded formulations due to lower manufacturing and marketing costs. Prices vary by pharmacy and insurance coverage; patients should consult local providers for specific pricing.
